首页> 中文期刊> 《世界核心医学期刊文摘:皮肤病学分册》 >原发眼睑的、系统性、CD30^+和间变性淋巴瘤激酶(ALK)阴性的间变性大细胞淋巴瘤(ALCL)的皮肤表现

原发眼睑的、系统性、CD30^+和间变性淋巴瘤激酶(ALK)阴性的间变性大细胞淋巴瘤(ALCL)的皮肤表现

         

摘要

Aim:To report an unusual case of cutaneous presentation on the eyelid of systemic(or nodal),CD30+,anaplastic large-cell lymphoma(ALCL).Methods:A 39-year-old man presented with a rapidly growing exophytic mass on the left upper eyelid,with a protuberant,ulcerated aspect and with discharge.The patient showed lymph node involvement 3 months after the appearance of the lesion on the eyelid(the lesion itself appeared 1 week before examination).Results:The histopathologic and immunohistoc hemical diagnosis was ALCL,T-cell phenotype,strongly positive for CD43 and CD30,and negative for CD3,anaplastic lymphoma kinase(ALK),and B-cell antigens.Treatment was by radiotherapy and,later,chemotherapy(cyclophosphamide,adriamycin,vincristine,and prednisolone,CHOP)for skin recurrences and lymphadenopathies over 5 years.There has been no recurrence for more than 6 years.Conclusions:Primary,systemic,CD30+,ALK-negative,ALCL presentations generally have a poor prognosis and tend to occur in older individuals,although the clinical outcome is highly variable and difficult to predict in individual cases.Only three cases of ALCL have been described in the ocular adnexae and none was ALK-negative.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号